Gabelli Funds Decreased By $1.47 Million Its Ametek New Com (AME) Holding; Winslow Capital Management Has Upped By $54.31 Million Its Boston Scientific (BSX) Holding

December 7, 2017 - By Kurt Siggers

Gabelli Funds Llc decreased Ametek Inc New Com (AME) stake by 1.41% reported in 2017Q2 SEC filing. Gabelli Funds Llc sold 24,500 shares as Ametek Inc New Com (AME)’s stock rose 10.20%. The Gabelli Funds Llc holds 1.71 million shares with $103.61M value, down from 1.74 million last quarter. Ametek Inc New Com now has $16.42B valuation. The stock decreased 0.01% or $0.01 during the last trading session, reaching $71.04. About 729,686 shares traded. AMETEK, Inc. (NYSE:AME) has risen 27.71% since December 7, 2016 and is uptrending. It has outperformed by 11.01% the S&P500.

Winslow Capital Management Llc increased Boston Scientific Corp (BSX) stake by 21.86% reported in 2017Q2 SEC filing. Winslow Capital Management Llc acquired 2.01 million shares as Boston Scientific Corp (BSX)’s stock rose 4.02%. The Winslow Capital Management Llc holds 11.21 million shares with $310.82 million value, up from 9.20 million last quarter. Boston Scientific Corp now has $34.66 billion valuation. The stock increased 1.20% or $0.3 during the last trading session, reaching $25.24. About 12.02M shares traded or 72.00% up from the average. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since December 7, 2016 and is uptrending. It has outperformed by 2.42% the S&P500.

Winslow Capital Management Llc decreased Zoetis Inc Cl A (NYSE:ZTS) stake by 2.58 million shares to 5.38M valued at $335.90 million in 2017Q2. It also reduced Apple Inc (NASDAQ:AAPL) stake by 1.07 million shares and now owns 5.53 million shares. Unitedhealth Group Inc (NYSE:UNH) was reduced too.

Investors sentiment increased to 1.03 in Q2 2017. Its up 0.14, from 0.89 in 2017Q1. It increased, as 41 investors sold BSX shares while 173 reduced holdings. 56 funds opened positions while 165 raised stakes. 1.22 billion shares or 0.64% less from 1.23 billion shares in 2017Q1 were reported. Asset Advsrs stated it has 0% in Boston Scientific Corporation (NYSE:BSX). Ubs Asset Mngmt Americas Inc holds 3.60 million shares. Legal General Group Public Ltd Co owns 6.53 million shares for 0.15% of their portfolio. Taurus Asset Mgmt Limited, New York-based fund reported 388,850 shares. Advisory Svcs Network Ltd Llc accumulated 0% or 1,002 shares. Lockheed Martin Mgmt Company has invested 0.21% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Td Asset Mgmt holds 0.02% or 457,060 shares. The Illinois-based Balyasny Asset Mngmt Lc has invested 0.22% in Boston Scientific Corporation (NYSE:BSX). 1.99M are owned by Manufacturers Life Insurance The. Utd Asset Strategies has invested 1.45% in Boston Scientific Corporation (NYSE:BSX). Crestwood Ltd Co owns 0.05% invested in Boston Scientific Corporation (NYSE:BSX) for 21,847 shares. Pggm Invs has invested 0.03% in Boston Scientific Corporation (NYSE:BSX). Citadel Ltd owns 1.55 million shares or 0.04% of their US portfolio. 1.23M were accumulated by Fil Ltd. Parametrica Mgmt has 0.21% invested in Boston Scientific Corporation (NYSE:BSX) for 7,887 shares.

Among 28 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 5 Hold. Therefore 82% are positive. Boston Scientific Corporation had 78 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, October 26. As per Monday, June 19, the company rating was maintained by BMO Capital Markets. The stock has “Buy” rating by Cowen & Co on Wednesday, November 29. The rating was downgraded by TheStreet to “Hold” on Thursday, August 13. The firm has “Neutral” rating given on Thursday, August 27 by Goldman Sachs. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Neutral” rating by Wedbush on Friday, July 29. Needham maintained the stock with “Buy” rating in Friday, February 3 report. The rating was maintained by RBC Capital Markets with “Buy” on Monday, October 2. The rating was initiated by SunTrust on Thursday, February 25 with “Buy”. The rating was initiated by UBS on Tuesday, September 22 with “Buy”.

Analysts await AMETEK, Inc. (NYSE:AME) to report earnings on February, 6. They expect $0.67 earnings per share, up 15.52% or $0.09 from last year’s $0.58 per share. AME’s profit will be $154.85M for 26.51 P/E if the $0.67 EPS becomes a reality. After $0.66 actual earnings per share reported by AMETEK, Inc. for the previous quarter, Wall Street now forecasts 1.52% EPS growth.

Gabelli Funds Llc increased Post Holdings Inc (NYSE:POST) stake by 17,700 shares to 585,000 valued at $45.43M in 2017Q2. It also upped Cohen & Steers Inc Com (NYSE:CNS) stake by 24,229 shares and now owns 189,829 shares. Waste Connections Inc was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :